NASDAQ:BCLI
Brainstorm Cell Therapeutics Inc. Stock News
$0.368
-0.0060 (-1.60%)
At Close: May 07, 2024
Analyzing Denali Therapeutics (NASDAQ:DNLI) and Brainstorm Cell Therapeutics (NASDAQ:BCLI)
05:52am, Thursday, 26'th Mar 2020
Denali Therapeutics (NASDAQ:DNLI) and Brainstorm Cell Therapeutics (NASDAQ:BCLI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the s
The autologous cell therapy market size has the potential to grow by USD 1.97 billion during 2020-2024.
Brainstorm Therapeutics Shares Pare All Recent Gains Since Trader Circulation Of Co. Tweet; Shares Still Up 8% for Session
12:00am, Tuesday, 24'th Mar 2020
Global Autologous Cell Therapy Market 2020-2024 The analyst has been monitoring the global autologous cell therapy market 2020-2024 and it is poised to grow by USD 1.97 bn during 2020-2024, progressin
130 Biggest Movers From Yesterday
10:06am, Wednesday, 18'th Mar 2020
Gainers
Blue Apron Holdings, Inc. (NYSE: APRN) shares gained 71.5% to close at $6.55 after surging over 67% on Monday.
BioNTech SE (NASDAQ: BNTX) gained 66.5% to close at $66.60...
94 Stocks Moving In Tuesday's Mid-Day Session
04:41pm, Tuesday, 17'th Mar 2020
Gainers
Waitr Holdings Inc. (NASDAQ: WTRH) jumped 64.1% to $0.9042 after surging 75% on Monday.
BioNTech SE (NASDAQ: BNTX) gained 60.6% to $64.24. Pfizer and BioNTech confirmed...
BrainStorm to Hold a Conference Call to Update Investors on Corporate Steps Taken to Address COVID-19
07:00am, Monday, 16'th Mar 2020
Funding Secured and Senior Management Team Activated by CEO to Ensure Advancement of all Operational Activities and Completion of Corporate Clinical Milestones Call.
BrainStorm to Hold a Conference Call to Update Investors on Corporate Steps Taken to Address COVID-19
12:00am, Monday, 16'th Mar 2020BrainStorm Cell Therapeutics Raises $10.0 Million in Common Stock Sale at $8.00 Per Share
02:25pm, Friday, 06'th Mar 2020
BrainStorm Cell Therapeutics Inc., (NASDAQ: BCLI), a leading developer of cell technologies for neurodegenerative diseases, today announced that it has entered into a definitive agreement with Abbhi I
101 Biggest Movers From Yesterday
09:28am, Friday, 06'th Mar 2020
Gainers
Cohen & Company Inc. (NYSE: COHN) shares climbed 27.8% to close at $5.11 on Thursday. The Israeli company posted a Q4 profit of $0.56 per share, versus a year-ago...
BrainStorm Cell Therapeutics Prices 1.25M Common Stock Offering At $8/Share
12:00am, Friday, 06'th Mar 2020
So far Thursday, March 5, NASDAQ is up 0.22% and the S&P is down -0.82%. Here are this morning’s most
Coal miner's 'fake analysis' probe never queried lab
01:00pm, Sunday, 01'st Mar 2020
TerraCom has resoundingly rejected claims that its coal quality had been faked.
Fifth and Final Site Announced for BrainStorm’s Progressive Multiple Sclerosis Phase 2 Clinical Trial
06:00am, Thursday, 27'th Feb 2020
NEW YORK and BOSTON, Feb. 27, 2020 -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating.
